BlackRock Portfolio holdings
BlackRock is an asset manager that runs the iShares family of exchange-traded funds. It was founded in 1988 by Larry Fink, a mortgage-bond pioneer at First Boston, and several colleagues, to manage money for institutions with a focus on risk. Blackstone backed the start-up in exchange for a stake in its bond business, and the two parted ways in 1994. BlackRock went public in 1999 and merged with the investment managers division of Merrill in 2006. BlackRock bought the iShares business from Barclays in 2010 and the private credit manager HPS Investment Partners in 2025. It also sells technology: its Aladdin platform gives institutional investors tools for portfolio management, risk analysis, trading and accounting, and its BlackRock Solutions unit, launched in 2000, advises on risk management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$8.67B |
| 2 |
Microsoft
MSFT
|
+$5.68B |
| 3 |
HONA
Honeywell Aerospace
HONA
|
+$5.24B |
| 4 |
Apple
AAPL
|
+$5.23B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$5.04B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$5.81B |
| 2 |
Coterra Energy
CTRA
|
+$2.24B |
| 3 |
Intel
INTC
|
+$2.13B |
| 4 |
Qualcomm
QCOM
|
+$2.03B |
| 5 |
Hologic
HOLX
|
+$1.7B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.75% |
| 2 | Financials | 11.04% |
| 3 | Industrials | 9.81% |
| 4 | Healthcare | 9.52% |
| 5 | Consumer Discretionary | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4426
iBio
IBIO
$51.1M
| $424K | ﹤0.01% |
242,016
+110,801
| +84% | +$198K |
2017 Q1
37 quarters
|
|
4427
Cerenome
CNSY
$4.32M
| $419K | ﹤0.01% |
95,983
+24,928
| +35% | +$136K |
2016 Q2
40 quarters
|
|
4428
ProShares S&P 500 ex-Health Care ETF
SPXV
$39.9M
| $418K | ﹤0.01% |
5,083
| – | – |
2025 Q4
2 quarters
|
|
4429
iShares Expanded Tech-Software Sector ETF
IGV
$12.7B
| $415K | ﹤0.01% |
4,583
-3,032
| -40% | -$270K |
2025 Q2
4 quarters
|
|
4430
WisdomTree US High Dividend Fund
DHS
$1.66B
| $415K | ﹤0.01% |
3,651
+132
| +4% | +$14.7K |
2024 Q4
6 quarters
|
|
4431
Northern Technologies International Corp
NTIC
$70.7M
| $413K | ﹤0.01% |
48,268
+7,452
| +18% | +$60.1K |
2017 Q1
37 quarters
|
|
4432
GameSquare
GAME
$34M
| $413K | ﹤0.01% |
130,614
| – | – |
2025 Q3
3 quarters
|
|
4433
Cumberland Pharmaceuticals
CPIX
$80.5M
| $412K | ﹤0.01% |
63,547
+6,656
| +12% | +$31.9K |
2017 Q1
37 quarters
|
|
4434
First Trust Value Line Dividend Fund
FVD
$8.2B
| $412K | ﹤0.01% |
8,544
-379
| -4% | -$18.1K |
2025 Q3
3 quarters
|
|
4435
XBP Global Holdings
XBP
$41.1M
| $410K | ﹤0.01% |
176,686
+2,831
| +2% | +$7.58K |
2024 Q2
8 quarters
|
|
4436
Euroseas
ESEA
$456M
| $409K | ﹤0.01% |
6,166
| – | – |
2023 Q3
11 quarters
|
|
4437
Sundial Growers
SNDL
$343M
| $407K | ﹤0.01% |
301,640
-19,115
| -6% | -$27.4K |
2023 Q3
11 quarters
|
|
4438
Sera Prognostics
SERA
$87.1M
| $403K | ﹤0.01% |
221,369
+25,264
| +13% | +$50.1K |
2021 Q3
19 quarters
|
|
4439
VirTra
VTSI
$28.4M
| $402K | ﹤0.01% |
127,898
+848
| +0.7% | +$3.23K |
2019 Q4
26 quarters
|
|
4440
Grupo Aval
AVAL
$5.15B
| $397K | ﹤0.01% |
78,921
-27,980
| -26% | -$132K |
2021 Q1
21 quarters
|
|
4441
StealthGas
GASS
$299M
| $397K | ﹤0.01% |
50,204
+254
| +0.5% | +$2.39K |
2024 Q3
7 quarters
|
|
4442
Powerus Corporation Common Stock
PUSA
$257M
| $394K | ﹤0.01% |
98,818
+95,934
| +3,326% | +$402K |
2026 Q1
1 quarter
|
|
4443
Odyssey Marine Exploration
OMEX
$25.2M
| $390K | ﹤0.01% |
18,352
+2,674
| +17% | +$68.2K |
2017 Q1
37 quarters
|
|
4444
Fidelity MSCI Health Care Index ETF
FHLC
$4.03B
| $390K | ﹤0.01% |
5,047
+327
| +7% | +$23.5K |
2025 Q3
3 quarters
|
|
4445
Vince Holding Corp
VNCE
$170M
| $390K | ﹤0.01% |
54,516
+19,738
| +57% | +$90.9K |
2013 Q4
50 quarters
|
|
4446
BBB Foods
TBBB
$8.15B
| $389K | ﹤0.01% |
9,340
+6,406
| +218% | +$244K |
2024 Q3
7 quarters
|
|
4447
Canaan Creative
CAN
$148M
| $389K | ﹤0.01% |
1,354,418
-19,165
| -1% | -$8.33K |
2021 Q2
20 quarters
|
|
4448
FitLife Brands
FTLF
$77.2M
| $388K | ﹤0.01% |
35,275
-122,129
| -78% | -$1.23M |
2024 Q2
8 quarters
|
|
4449
Actinium Pharmaceuticals
ATNM
$48.4M
| $388K | ﹤0.01% |
395,896
+24,686
| +7% | +$28.5K |
2017 Q1
37 quarters
|
|
4450
Caesarstone
CSTE
$52.9M
| $385K | ﹤0.01% |
183,229
-5,255
| -3% | -$8.62K |
2015 Q4
42 quarters
|
|
Similar funds
BlackRock's Q2 2026 Portfolio in Review
As of Q2 2026, BlackRock held 5,933 positions worth $6.73T, up 18% from $5.72T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BlackRock's Q2 2026 filing shows 244 new, 3,464 increased, 1,293 reduced and 235 closed positions. Its largest new stake was SpaceX: 51,037,137 shares worth $8.72B. The largest sale was Honeywell, an estimated $5.81B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Industrials.
- BlackRock's largest Q2 2026 buy was SpaceX: 51,037,137 shares worth $8.72B.
- BlackRock added most to Microsoft in Q2 2026, an estimated $5.68B increase.
- BlackRock's biggest Q2 2026 reduction was Honeywell, cutting an estimated $5.81B.
- BlackRock fully exited Coterra Energy in Q2 2026, selling an estimated $2.24B.
- BlackRock's ten largest holdings make up 28% of its $6.73T portfolio in Q2 2026.
- BlackRock opened 244 new positions and closed 235 in Q2 2026.
- BlackRock's portfolio value rose 18% quarter-over-quarter to $6.73T.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.